Ocean Biomedical partners to bring hepatitis B drug to human trials
The goal of the new joint venture is to develop treatments for cancer and infectious diseases using T cell-based immunotherapies.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Mary Serreze Source Type: news
More News: Cancer | Cancer & Oncology | Health Management | Hepatitis | Hepatitis B | Immunotherapy | Infectious Diseases | Pharmaceuticals